• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Antiviral Assault Gains Ground

MedMagSpring10-Virus EntryA NATIONAL GROUP OF RESEARCHERS led by a team from UCLA may have found a broad-spectrum antiviral that will fight a host of viruses by attacking them through some feature that is common to an entire class of viruses, without producing unwanted side effects.

In a proof-of-principle study published online in Proceedings of the National Academy of Sciences, the researchers have identified an antiviral small molecule that is effective against numerous viruses, including HIV-1, influenza A, filoviruses, poxviruses, arenaviruses, bunyaviruses, paramyxoviruses and flaviviruses. These viruses cause some of the world’s deadliest diseases, such as AIDS, Nipah virus encephalitis, Ebola, hemorrhagic fever and Rift Valley fever. Even better, the compound – a rhodanine derivative that the researchers have dubbed LJ001 – could be effective against new, yet-to-be discovered enveloped viruses.

U.S. Food and Drug Administration-approved broad-spectrum antivirals do exist but are rare, for various reasons. They are effective against only a limited number of viruses, for example, or they have unwanted side effects or are too expensive for widespread use. But the putative mechanism for LJ001 is surprising, says Benhur Lee, M.D., associate professor of microbiology, immunology and molecular genetics. “We provide evidence that the small molecule binds to both cellular and viral membranes, but its preferential ability to inactivate viral membranes comes from its ability to exploit the biogenic reparative ability of metabolically active cells versus static viral membranes,” he says. “That is, at antiviral concentrations, any damage it does to the cell’s membrane can be repaired, while damage done to static viral membranes, which have no inherent regenerative capacity, is permanent and irreversible.”

While the exact mechanism of viral membrane inactivation is unknown, the researchers – including scientists from the University of Texas at Galveston, Harvard University, Cornell University and the United States Army Medical Research Institute of Infectious Diseases – are pursuing some promising leads that could answer that question.


Previous
Genes + Environment = Disease Risk
Next
Why the Mirror Lies


YOU ARE VIEWING

Spring 2010

Spring 2010
E-Brochure
Printable PDF
IN THIS ISSUE
  • New Beginning
  • Quit Smoking, Save Your Vision
  • A Week of Hope and Healthcare
  • There's No Place Like Home
  • Another Step Toward Understanding Schizophrenia
  • Don't Assume HIV Vaccine Would Be Accepted
  • Sticky Solution
  • The Frailer Generation
  • Genes + Environment = Disease Risk
  • Antiviral Assault Gains Ground
  • Why the Mirror Lies
  • Dr. A. Eugene Washington
  • UCLA REACHES OUT TO HAITI
  • LETTING GO
  • ADVANCING THE ETHICS DEBATE
  • A Matter of the Heart
  • The Real World
  • Endless Summer
  • Snapshot Gerald A.M. Finerman, MD
  • Awards/Honors
  • GRANTS
  • IN MEMORIAM
  • In His Own Words: Keyvan Hariri, M.D.
  • MAA Reaches Out to Residents
  • Mobile Clinic Needs Volunteers
  • Update: Books Without Borders
  • Patent Pending
  • Humanitarian Medicine 101
  • What's Your Story?
  • Boy Wonder
  • In Memoriam
  • EVENTS
  • Supporting Scholarships
  • Gifts
  • My Long and Winding Road
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth